Iron: the hard player in diabetes pathophysiology.

Area of Science:

• Endocrinology
• Metabolic Disease Research
• Cellular Biology

Background:

• Recent evidence highlights iron's critical role in diabetes pathophysiology, influencing pancreatic islet inflammation and serving as a biomarker for diabetes risk.
• Iron metabolism in pancreatic beta cells is complex, with excess iron being toxic yet essential for normal function and glucose homeostasis.

Purpose of the Study:

• To review and discuss current evidence implicating iron as a key pathogenic factor in both type 1 and type 2 diabetes.
• To focus on the role of inflammatory pathways in iron-mediated beta-cell damage.

Main Methods:

• Review of recent scientific literature on iron metabolism, diabetes, inflammation, and oxidative stress.
• Analysis of proposed mechanisms linking pro-inflammatory cytokines, iron uptake, and beta-cell apoptosis.

Main Results:

• Iron generates reactive oxygen species (ROS) via Fenton chemistry, leading to oxidative damage and apoptosis in beta cells.
• Pro-inflammatory cytokine IL-1β enhances beta-cell iron uptake via DMT1, promoting ROS formation and apoptosis, linking inflammation to oxidative damage.
• Iron-induced ROS may contribute to beta-cell dedifferentiation and death through various cellular pathways.

Conclusions:

• Iron plays a significant role in the pathogenesis of both type 1 and type 2 diabetes, particularly through inflammatory pathways.
• Iron chelation presents a potential therapeutic avenue for reducing diabetes severity and mortality.
• Further clinical trials are necessary to evaluate the efficacy and safety of iron reduction therapies in diabetes management.